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S74Objective: This study was undertaken to examine the possible adverse effect of the mitral valve prosthesis on
the hemodynamic performance of the aortic valve prosthesis in patients who have undergone double valve re-
placement.
Methods: Patients who underwent double valve replacement were matched for age, body surface area, left ven-
tricular function, and size and type of aortic valve prosthesis with patients who underwent isolated aortic valve
replacement. Two types of prosthetic valves were examined: the St Jude Medical mechanical valve (St Jude
Medical, St Paul, Minn) and the Hancock II bioprosthesis (Medtronic Inc, Minneapolis, Minn). Five patients
for each size and type of aortic valve prosthesis in the double valve replacement group were matched at 1:2
with patients in the isolated aortic valve replacement group. Only valve sizes 21 to 27 were matched. Hemody-
namic assessment of the aortic valve prosthesis was performed by transthoracic echocardiogram before hospital
discharge.
Results: Matched patients had similar clinical profiles. There were no differences in the systolic gradients, ef-
fective aortic valve areas, or flow velocity across the aortic valve prostheses after isolated aortic valve replace-
ment or double valve replacement.
Conclusions: Early after surgery, the hemodynamic performance of aortic valve prostheses was not affected by
the presence of mitral valve prostheses in patients who underwent combined aortic andmitral valve replacement.
(J Thorac Cardiovasc Surg 2012;143:S74-7)Replacement of the aortic and mitral valves is a complex
operation and requires greater anatomic knowledge of the
left ventricular inflow tract and let ventricular outflow tract
(LVOT) because of the anatomic continuity between the
aortic and mitral valves. This is particularly true when the
mitral valve is replaced by bioprosthetic valves with stents
that may protrude into the LVOT if incorrectly oriented dur-
ing implantation. A study1 published in 1980 on the hemo-
dynamic features of 7 patients who underwent combined
aortic valve replacement (AVR) and mitral valve replace-
ment (MVR), that is, double valve replacement (DVR),
with pericardial bioprostheses suggested that the effective
orifice areas were similar to those of historical controls of
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The Journal of Thoracic and Cardiovascular SurgWe hypothesized that the presence of a mitral valve pros-
thesis in patients who have undergone DVR adversely af-
fects the hemodynamic performance of the aortic valve
prosthesis because it interferes with the movements of the
intervalvular fibrous body during systole. In addition, cer-
tain mitral valve prostheses protrude into the LVOT even
when correctly implanted. We could not find any informa-
tion in the medical literature regarding this issue. Thus,
we designed a retrospective study whereby we compared
the hemodynamic performance of aortic valve prostheses
in patients who underwent DVR with that of similar aortic
valve prostheses in patients who underwent isolated AVR.PATIENTS AND METHODS
Patients’ clinical and operative data and in-hospital outcomes were col-
lected prospectively and entered into a computerized database. Our institu-
tional review ethics board approved this retrospective study, and patients’
consents were waived. We reviewed the records of all patients who under-
went DVR between January 1, 1990, and August 31, 2008, with the same
type of prosthetic valve in themitral and aortic positions. Only patients who
left the hospital alive without early reoperation were included in the study.
Two types of prosthetic valves were examined: the St Jude Medical
mechanical valve (St Jude Medical, St Paul, Minn) and the Hancock II bio-
prosthesis (Medtronic Inc,Minneapolis,Minn). Patientswith a preoperative
or postoperative left ventricular ejection fraction less than 40% and pa-
tients who had cardiac procedures other than DVR with or without coro-
nary artery bypass were excluded. We randomly selected 5 patients who
underwent DVR for each type and size of prosthetic aortic valve, andery c April 2012
Abbreviations and Acronyms
AVR ¼ aortic valve replacement
DVR ¼ double valve replacement
MVR ¼ mitral valve replacement
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for valve size and type, age (10 years), body surface area (10%), and
left ventricular ejection fraction (40%–54% and 55% only; those with
an ejection fraction<40% were excluded). Thus, we included 20 patients
who underwent DVR and 40 patients who underwent isolated AVR for each
type of valve. After these patients were matched, we retrieved their echo-
cardiograms taken before hospital discharge. The following hemodynamic
data on the aortic valve prostheses were examined: aortic valve area, peak
systolic gradient, mean gradient, flow velocity across the aortic valve, and
aortic regurgitation. We collected the hemodynamic data on the mitral
valve prosthesis in patients who underwent DVR and examined and
compared the preoperative risk profile of the 2 cohorts of patients (AVR
and DVR).
Statistical Analysis and Presentation
All statistical analyses were conducted with SAS 9.1 software (SAS
Institute Inc, Cary, NC).2 Categoric variables were analyzed using the
chi-square or Fisher exact test and are expressed as percentages. Continu-
ous variables with normal distribution were analyzed by the Student t test,
and the Wilcoxon rank-sum test was used for continuous variables with
skewed distribution. Data from continuous variables are reported as
mean  standard deviation or median where appropriate.RESULTS
The preoperative risk profile of the 2 patient cohorts
(AVR and DVR) was generally similar, with the exception
of a higher prevalence of symptoms of congestive heart fail-
ure and a higher incidence of atrial fibrillation in the DVR
group compared with the AVR group (Table 1).
The hemodynamic data of the aortic prosthesis in the
DVR and AVR groups are shown in Table 2. The hemody-
namic performance of the aortic valve prosthesis was simi-
lar for every size whether the mitral valve had been replaced
or not, negating our hypothesis that the mitral valve prosthe-
sis has a detrimental effect on the hemodynamics of the aor-
tic valve prosthesis in patients who underwent DVR. We
could not identify any other variable, such as aortic insuffi-
ciency or the hemodynamic performance of the mitral valve
prosthesis, to explain these findings.DISCUSSION
DVR is a complex operation associated with a higher op-
erativemortality than isolated AVR orMVR.3 In a recent re-
port on the perioperative outcomes of heart valve surgery in
623.039 patients from the database of the Society of Tho-
racic Surgeons, DVR represented only 6.3% of all valve op-
erations and was associated with an overall operative
mortality of 10.7%, whereas the operative mortality was
4.9% for AVR and 6.3% for MVR.3 Numerous patientThe Journal of Thoracic and Carvariables affect operative mortality in DVR, but technical
difficulties in replacing both valves also play an important
role. The senior author of this study has performed reoper-
ations in several patients who underwent DVR at other in-
stitutions, and severe LVOT obstruction developed
because of incorrect orientation of the mitral valve biopros-
thesis. There are no data on how often this technical error
occurs, but experienced surgeons know that MVR with
high-profile valves can be a problem, particularly in female
patients with mitral stenosis and a small left ventricular cav-
ity. In addition, bioprosthetic mitral valve stents have also
been blamed for some cases of left ventricular wall rupture
after MVR.4
Implantation of a prosthetic valve in the mitral position
deforms the intervalvular fibrous body and makes it rigid.
In addition, all prosthetic mitral valves protrude to some de-
gree into the LVOT. During DVR, the MVR is performed
first, and visual inspection of the LVOT before implanting
the aortic valve prosthesis invariably shows some degree
of protrusion of the mitral valve prosthesis into the LVOT,
particularly when the intervalvular fibrous body is short.
The mitral valve prosthesis narrows the diameter of the
LVOT and prevents the intervalvular fibrous body from
moving away from the interventricular septum during sys-
tole. If the diameter of the aortic annulus and outflow tract
is sized before and after implantation of the mitral valve
prosthesis during DVR, there is often a reduction in aortic
valve size selection, particularly in patients with rheumatic
heart disease and a small ventricular cavity.
For these reasons, we have postulated that the anatomic
abnormality caused by the presence of a prosthetic mitral
valve adversely affects the hemodynamic function of the
aortic valve prosthesis in patients who have undergone
DVR. To verify this hypothesis, the present study was con-
ducted, whereby we compared the hemodynamics of the
aortic valve prosthesis in patients who underwent DVR
with those of patients who underwent isolated AVR with
the same size and type of prosthetic valve. The results of
this study failed to confirm our hypothesis, because the
hemodynamics of the prosthetic aortic valves seem to be
similar whether they are implanted in isolation or in combi-
nation with mitral valve prostheses.
Study Limitations
As scientifically sound as we believed our hypothesis to
be, we could not demonstrate its validity in the cohort of
patients studied. Therefore, it is possible that our hypothe-
sis was erroneous, and that the alterations in the LVOT
caused by fixation of the intervalvular fibrous body with
rigid mitral valve prostheses and the variable degree of
protrusion of the prostheses into the LVOT are irrelevant
to the hemodynamic function of prosthetic aortic valves
in patients with DVR. However, it is also possible we could
not prove our hypothesis because prosthetic aortic valvesdiovascular Surgery c Volume 143, Number 4S S75
TABLE 1. Cardiac profile and valve pathophysiology of patients
Aortic valve size 21 22 25 27
Variable AVR DVR P AVR DVR P AVR DVR P AVR DVR P
St Jude Medical (St Jude Medical,
St Paul, Minn)
Cardiac comorbidity
Hypertension 60 20 .3 70 60 1 40 20 .6 50 20 .6
Dyslipidemia 50 40 1 70 20 .1 40 40 1 30 20 1
Congestive heart failure 20 100 .007 10 100 .002 20 80 .09 40 60 .6
Atrial fibrillation/flutter 20 80 .09 0 60 .02 0 40 .1 0 60 .02
NYHA class IV 20 0 .5 10 0 1 10 20 1 30 20 1
Valve pathophysiology
Aortic stenosis 90 20 .02 80 40 .3 70 20 .17 30 0 .07
Insufficiency 0 40 0 20 10 40 70 60
Mixed 10 40 20 40 20 40 0 40
AV pathology
Rheumatic 0 100 .001 0 100 .001 0 80 .0007 10 0 .6
Calcified 50 0 50 0 20 0 0 20
Bicuspid 50 0 50 0 60 0 30 20
Prosthetic dysfunction/
congenital/other
20 20 60 60
MV disease
Stenosis N/A 80 N/A N/A 100 N/A N/A 40 N/A N/A 0 N/A
Regurgitation N/A 20 N/A 0 N/A N/A 20 N/A 100
Mixed N/A 0 N/A 0 N/A N/A 40
MV pathology
Rheumatic N/A 80 N/A N/A 100 N/A N/A 80 N/A N/A 20
Ischemic/myxoma N/A 20 N/A 0 N/A N/A 20 N/A 80 N/A
Hancock II bioprosthesis (Medtronic
Inc, Minneapolis, Minn)
Cardiac comorbidity
Hypertension 70 100 .5 60 40 .6 60 40 .6 70 80 1
Dyslipidemia 80 40 .2 70 20 .1 70 20 .1 80 60 .6
Congestive heart failure 40 100 .04 40 100 .04 20 100 .007 10 60 .08
Atrial fibrillation/flutter 0 60 .02 20 40 .6 10 40 .2 10 40 .2
NYHA class IV 10 20 1 40 20 .6 20 40 .6 30 20 1
Valve pathophysiology
Aortic stenosis 90 40 .08 60 40 .5 100 20 .004 60 40 1
Insufficiency 10 20 0 20 0 60 30 40
Mixed 0 40 40 40 0 20 10 20
AV pathology
Rheumatic 0 80 .001 10 80 .1 0 20 .02 0 40 .1
Calcified 70 0 50 20 60 40 60 20
Bicuspid 20 20 20 0 40 0 20 20
Prosthetic dysfunction/
congenital/other
10 0 20 0 0 40 20 20
MV disease
Stenosis N/A 40 N/A N/A 80 N/A N/A 0 N/A N/A 20 N/A
Regurgitation N/A 20 N/A 20 N/A N/A 80 N/A 40
Mixed N/A 40 N/A 0 N/A N/A 20 40
MV pathology
Rheumatic N/A 100 N/A N/A 100 N/A N/A 20 N/A N/A 60 N/A
Other (ischemic, myxomatous,
prosthetic dysfunction)
N/A 0 N/A 0 N/A N/A 80 N/A 40
AVR, Aortic valve replacement; DVR, double valve replacement; AV, atrioventricular; N/A, not applicable; MV, mitral valve; NYHA, New York Heart Association.
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TABLE 2. Demographics and aortic prosthesis hemodynamics of patients
Aortic valve size 21 23 25 27
Variable AVR DVR P AVR DVR P AVR DVR P AVR DVR P
St Jude Medical
Age (y) 63  7 63  6 1 61  5 61  5 1 57  8 58  10 .8 42  11 42  12 .9
BSA 1.66  0.12 1.62  0.12 .6 1.99  0.14 1.99  0.2 1 1.98  0.16 2.03  0.18 .6 2.2  0.3 2.2  0.1 .9
Female (%) 70 80 1 10 60 .08 10 0 1 0 0 N/A
AVA cm2 1.39  0.18 1.51  0.26 .3 1.33  0.22 1.3  0.2 .8 1.50  0.27 1.29  0.11 .1 1.50  0.48 1.48  0.3 .9
PG mm Hg 28.5  7.6 24.7  9.2 .5 28.3  8.2 22.8  6.8 .2 26.7  13.9 22.6  6.5 .8 24.2  6.1 26.2  5.7 .4
MG mm Hg 13.6  3.7 11.6  5.1 .4 14.3  5.9 11.2  4.3 .4 12.8  6.9 10.8  3.5 .6 12.8  3.1 13.4  2.7 .7
AvVel m/sec 2.4  0.6 2.4  0.8 .8 2.6  0.4 2.4  0.3 .5 2.5  0.7 2.4  0.5 .7 2.5  0.2 2  0.3 .8
Hancock II bioprosthesis
Age (y) 75  4 74  4 .8 70  14 69  16 .9 70  11 70  12 1 71  9 71  10 1
BSA 1.65  0.17 1.64  0.17 .9 1.66  0.11 1.65  0.11 .9 1.94  0.12 1.87  0.12 .3 1.93  0.14 1.95  0.11 .8
Female (%) 100 80 .3 30 100 .03 10 20 1 0 20 .3
AVA cm2 1.2  0.3 1.14  0.2 .6 1.3  0.24 1.24  0.1 .7 1.39  0.22 1.2  0.23 .2 1.4  0.24 1.4  0.35 .9
PG mm Hg 30.9  11.8 34.1  14 .9 26.8  8.3 20.4  4.5 .1 26  12 25.4  6.5 .9 22.3  4.5 27.8  16.5 .7
MG mm Hg 16  6.6 17.4  10.5 .8 13.2  5.3 11.3  0.6 .9 13.7  6.49 12  2.45 1 12.3  2.8 12.4  7.4 .5
AvVel m/sec 2.6  0.45 2.7  0.3 .7 2.5  0.4 2.2* .5 2.5  0.5 2.5  0.5 1 2.3  0.2 2.4  0.1 .4
All values are given as mean standard deviation of the mean. AVR,Aortic valve replacement;DVR, double valve replacement;N/A, not applicable; BSA, body surface area; AVA,
aortic valve area; PG, peak systolic gradient; MG, mean systolic gradient; AvVel, flow velocity across aortic valve. *Only 1 patient had flow velocity recorded.
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smaller than the actual sizes of the aortic annuluses where
they are anchored, and the effect of the mitral valve pros-
thesis was confounded by the degree of intrinsic obstruc-
tion of prosthetic aortic valves.
Other reasons that could explain the outcomes of this
comparative study are the limited sample size of patients
who have undergone DVR, given the large number of con-
founding factors that affect blood flow across the LVOT in
these patients. In addition, the pathology and the valve le-
sion were not matched, and most patients who underwent
DVR had rheumatic heart valve disease. Finally, the timing
of echocardiographic evaluation of the prosthetic aortic
valves may play a role on the outcomes. In ideal circum-
stances, such a study should be conducted after patients
have completely recovered from surgery, and the valveThe Journal of Thoracic and Carhemodynamics should be assessed at rest and during maxi-
mum exercise.
CONCLUSIONS
The presence of mitral valve prosthesis in patients who
have undergone DVR has no effect on the early hemody-
namic features of the prosthetic aortic valve, as assessed
by echocardiography early after surgery.
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